Sort by
Refine Your Search
-
Employer
- BIOGIPUZKOA HEALTH RESEARCH INSTITUTE
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Josep Carreras Leukaemia Research Institute (IJC)
- CIC bioGUNE
- Centre de Recerca en Agrigenòmica
- Computer Vision Center
- FUNDACIÓ ESADE - UNIVERSITAT RAMON LLULL
- Fundación IIS Aragón
- ICN2
- Institute for bioengineering of Catalonia, IBEC
- The Chinese Institutes for Medical Research (CIMR), Beijing
- 1 more »
- « less
-
Field
-
patients responds to the therapy. Biomarkers are biological indicators that can allow to identify patients that will, or will not, respond to a particular treatment. But patient selection based on currently
-
bioGUNE (Bilbao-Spain), led by Dr. Ana Ruiz-Saenz, strive to understand the molecular mechanisms underlying resistance to targeting therapies. Current and future projects are exploring new aspects
-
. Participation in the cannulation and extraction of porcine organs from animal models, following established research protocols. Support in training in the extraction and cannulation of porcine kidneys and livers
-
Computational Nanoscience group at ICN2 develops theory, models and large-scale simulation tools for quantum transport, spin dynamics and emergent computing in low-dimensional materials, in close contact with
-
these processes. The successful candidate will work with animal models and clinical samples and will apply a range of cutting-edge techniques, including flow cytometry, 3D microscopy and transcriptomic analyses
-
biological validations of patterns identified in both cell cultures and tests on animal models. Where to apply Website https://gestiononline.bioef.eus/ConvocatoriasPropiasBiogipuzkoa/es/Convocatoria
-
Lymphoblastic Leukemia (B-ALL). The project takes a multidisciplinary approach, combining state-of-the-art molecular and cellular biology techniques with genomics, proteomics, metabolomics in mouse models and
-
on endocrine and neuroendocrine tumours, integrating preclinical models, molecular profiling and translational approaches to identify novel therapeutic vulnerabilities and biomarkers associated with treatment
-
studies in mouse models of disease. This role offers a defined period of advanced, mentored training, providing the opportunity to deepen expertise, contribute to high-quality research projects, and
-
, and methodologies from the collected materials, using Qualitative Comparative Analysis (QCA) and topic modeling Autonomous management of data collection and analysis activities Co-authorship of academic